
Sacituzumab govitecanPharmaceutical Reference StandardsIntermediates and building blockspharmaceutical standards
Sacituzumab GovitecanCAS 1491917-83-9
- Catalogue No.
- CSL-120270
- CAS No.
- 1491917-83-9
- Molecular formula
- NA
- Molecular weight
- NA
- Parent drug
- Sacituzumab govitecan
- Product type
- Pharmaceutical Reference Standards, Intermediates and building blocks, pharmaceutical standards, Fine Chemicals, Metabolites, Antibody Drug Conjugate
Quick quote · CSL-120270Price and availability on request
ISO 17034:2016 · GLPTell us the quantity you need, from a few milligrams upwards, and we reply within 24 hours with price, availability and delivery time.
Need documents or a larger lot? Use the full quote form
Synonyms
- Immunoglobulin G1, anti-(human tumor-associated calcium signal transducer 2) (human-Mus musculus monoclonal hRS7 heavy chain), disulfide with human-Mus musculus monoclonal hRS7 κ-chain, dimer, hexakis(thioether) with (4S)-4-[[[[4-[[(2S)-2-(4-aminobutyl)-2-[[2-[2-[[26-[4-[[[[trans-4-[(3-mercapto-2,5-dioxo-1-pyrrolidinyl)methyl]cyclohexyl]carbonyl]amino]methyl]-1H-1,2,3-triazol-1-yl]-3,6,9,12,15,18,21,24-octaoxahexacos-1-yl]amino]-2-oxoethoxy]acetyl]amino]-1-oxoethyl]amino]phenyl]methoxy]carbonyl]oxy]-4,11-diethyl-9-hydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- Anti-TROP 2-CL2A-SN 38
- Sacituzumab govitecan-hziy
Show all 4 synonyms
- IMMU 132

